Science behind Nutraceuticals

Newsletter Archive

Our association sends out a digital newsletter about news regarding of neutraceuticals to its members once a month. Non-members can be kept posted through a RSS feed.




Newsletter 02/10

Conference Update

Literature-Service - some Highlights




Literature-Service - some Highlights

For our monthly Literature-Service please click here.
We would like to pick out a few highlight publications and present these to you separately. 

A good summary about the health benefits of beta carotene: high blood levels seem to be protective. The primary reason fort his is that beta carotene is a marker for a diet rich in fruits and vegetables. The latter is once more considered as important eating behaviour.
Tell me what your blood beta-carotene level is, I will tell you what your health risk is! The viewpoint of the SUVIMAX researchers.
Ann Nutr Metab. 2009;54(4):310-2. Epub 2009 Sep 22. No abstract available.
Hercberg S, Czernichow S, Galan P.

High dose dietary supplementation of a single carotenoid may alter the assimilation of other carotenoids. The retina appears to have the capacity to preserve accumulation of lutein and zeaxanthin, but this capacity is diminished when intake of beta-carotene is high.
Competitive inhibition of carotenoid transport and tissue concentrations by high dose supplements of lutein, zeaxanthin and beta-carotene.
Eur J Nutr. 2010 Jan 16. [Epub ahead of print]
Wang Y, Roger Illingworth D, Connor SL, Barton Duell P, Connor WE.

A very helpful review about physiological and clinical effects of omega-3 fatty acids and the role of supplementation, by Philip Calder, a very well known speaker at two of our CME events.
Understanding omega-3 polyunsaturated fatty acids.
Postgrad Med. 2009 Nov;121(6):148-57. Review:
Calder PC, Yaqoob P

State of the art study in a top journal with the result of a 35% risk reduction of atrial fibrillation in subjects in the highest quartile of serum levels of LC-n-3-PUFA.
Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men.
Circulation. 2009 Dec 8;120(23):2315-21. Epub 2009 Nov
Virtanen JK, Mursu J, Voutilainen S, Tuomainen TP.

The preponderance of data from placebo-controlled treatment studies suggests that omega-3 fatty acids are a reasonable augmentation strategy for the treatment of major depressive disorder. Augmentation with omega-3 fatty acids should be considered, as general health benefits are well established and adjunctive use is low risk.
Omega-3 fatty acids in major depressive disorder.
J Clin Psychiatry. 2009;70 Suppl 7-11. Review:
Freeman MP.

Omega-3 fatty acids appear to be safe and might be helpful for children suffering from autistic spectrum disorder (ASD).
Omega 3 fatty acid treatment in autism.
J Child Adolesc Psychopharmacol. 2009 Aug;19(4):449-
Meiri G, Bichovsky Y, Belmaker RH.